Transatlantic early stage Venture Capital firm actively co-founding and investing in transformative healthcare companies targeting age-related diseases
Die Biowissenschaft erlebte einen starken Aufschwung. Derzeit trübt sich die Stimmung deutlich.
Vielen Dank an Andreas Huber (Bayern Kapital), Frank Hensel (@HTGF), Nils Regge (@apollohealthvc) und Dr. Peter Zobel (IZB) für die Einblicke! #lifescience
https://t.co/Iag8hjnOhW
Join Ole Mensching, Ph.D.(@apollohealthvc) at RESI JPM San Francisco, January 10 In Person & January 11-12 Virtual on the Longevity Investment panel. Hear from #agetech experts and their predictions for the future of this sector. Register: https://t.co/YjOuaMDjuT
#RESI#RESIJPM
At the @MilkenInstitute Middle East and Africa Summit, we are bringing together global experts to explore new knowledge, ideas, and innovations to enable longer and healthier lives for people across the planet. #longevity Tune in this Thursday: https://t.co/7TCrrVkxTS
Can we reverse ageing, stop age-related diseases and live healthy lives past 100?
With longevity investments on the rise, some definitely think so.
I spoke to @AlexandraBause and @marcpbernegger to find out more.
@apollohealthvc@maximon_ag#Longevity
https://t.co/K0CLQ1xMEs
Nils Regge founded @apollohealthvc to develop methods to prevent & reverse the aging process and extend healthy lifespan. In this episode, we learn about how Apollo invests in longevity—and the value of maintaining the right kinds of skepticism.
Episode: https://t.co/L6CzK3RrrY
Hear more from our new sponsor, Apollo Health Ventures, at #LongevityInvestors where Sebastian Pünzeler, Partner at Apollo Health Ventures, will be sharing investment insights. Secure your seat here: https://t.co/9Gv0nydKuV #ApolloHealth#LongevityInvestors#longevity
What are the #longevity opportunities and why the time is right to invest in #therapeutics against age-related disease and #aging itself?
Don't miss the keynote by Ole Mensching from @apollohealthvc at our 0100 Conference DACH (June 01).
See https://t.co/JTVUoOjvlN
#viennaup
It’s challenging to validate #longevity interventions in humans due to large heterogeneity and our relatively long #lifespan. Mice have been an imperfect yet insightful model providing clues on “The Most Promising Longevity Drugs To Date” @apollohealthvc https://t.co/ZSBET9qqDX
Great trajectory for Europe! Excited about Apollo's @apollohealthvc backing of Haya @HAYA_lncRNA as one of the top seed rounds. https://t.co/sehj5eHchf
@apollohealthvc does not just invest in exciting new #biotech#ventures, we also conceptualize and create them ourselves. Here’s an opportunity to join us for building the next generation of ventures to enhance #healthy#longevity!
#venturecreation
https://t.co/JggGF4yLqk
Big congrats to our friends at @apollohealthvc (@AkikoaCom#KF10) for closing their $180M Fund II! 🔥 They're working to extend the human healthspan by investing in data-driven #biotech + #healthtech ventures https://t.co/BiwUsWOQvG